RDEA-119
Posted by kinasepro on September 1, 2009
This PDB entry confirms the structure.
as always, being 18 months behind the times put you 6 months ahead of the curve.
Posted in MEK | 3 Comments »
p38: Not dead?
Posted by kinasepro on August 13, 2009
Well.. maybe this compound will kill it: Polymorphic Forms / WO/2009/098612 & its from Pfizer no less –
Part Axitinib, part Birb, Part SGX… All MW: 700
Thanks for the email PN.
Posted in p38, Pfizer | 8 Comments »
AT-131418
Posted by kinasepro on August 7, 2009
Astex has released data about their AKT program, including a PDB, but I have omitted that they appear to have dropped the strutcture of their candidate in WO/2008/110846
Thanks, Ed.
Posted in AKT, Astex | 1 Comment »
ENMD-2076
Posted by kinasepro on July 31, 2009
Its a salt form of ENMD-981693…
Posted in Aurora | 3 Comments »
AZ’s got PI3K
Posted by kinasepro on July 30, 2009
WO/2009/093972 reminds you of…
Posted in Astra, pi3k | 3 Comments »
Pi3k @ Bayer
Posted by kinasepro on July 25, 2009
This one hones in on the sulphonamides: (from the former site in CT)
WO/2009/091550; They stuck morpholines out there previously: WO/2008/070150
Posted in Bayer, pi3k | 1 Comment »
Biogen Nominated…
Posted by kinasepro on July 14, 2009
… A RAF candidate & Sunesis got a milestone,
In August 2004 the companies entered into a collaboration to discover and develop small molecule cancer therapeutics targeting kinases, a family of cell signaling enzymes that play a major role in the progression of cancer. The research term of this collaboration ended in June of 2008. Sunesis retains an option to participate in the co-development and co-promotion of the Raf kinase inhibitor resulting from this collaboration.
Likely derived from WO/2009/006389 & WO/2009/006404
Posted in Biogen, RAF, Sunesis | 2 Comments »
What do…
Posted by kinasepro on July 10, 2009
…the Bee Gee’s and R406 have in common?
R-788 (a prodrug of R-406) has shown promise in a Ph2b trial. Partner Plz?
still no BMCL
Posted in Rigel, SYK | 2 Comments »